Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00183365 · ClinicalTrials.gov registry record · Phase 1

Effect of Family-Based Prevention on Children of Depressed Parents

A Phase 1 study of Depression, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
Phase 1
Development phase
42
Enrollment target
1
Study location

NCT00183365: Completed Phase 1 study of Depression, sponsored by Children's Hospital of Philadelphia.

NCT00183365 is a Phase 1 study of Depression that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 42 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00183365, a Phase 1 study of Depression, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
Phase 1
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

This study will test the Protecting Families Program, a 10-week prevention program for depressed parents and their pre-teenage children, by comparing the effectiveness of the program versus parent training alone.

Conditions Studied

Interventions

  • BEHAVIORAL Parent Skills Training
  • BEHAVIORAL Protecting Families Program (PFP)

Study Locations (1)

Pennsylvania

  • Center for Family Intervention Science; The Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2005-10
Est. Completion 2009-11
Phase Phase 1
Children's Hospital of Philadelphia

431 total trials

What the finished NCT00183365 record still lists

NCT00183365 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Parent Skills Training is the first listed.

NCT00183365 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00183365 about?

NCT00183365 is a clinical study titled "Effect of Family-Based Prevention on Children of Depressed Parents". This study will test the Protecting Families Program, a 10-week prevention program for depressed parents and their pre-teenage children, by comparing the effectiveness of the program versus parent training alone.

What is the current status of trial NCT00183365?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2005-10. Estimated completion is 2009-11.

What conditions does trial NCT00183365 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT00183365?

The interventions under investigation include: Parent Skills Training (BEHAVIORAL), Protecting Families Program (PFP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00183365?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00183365 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00183365's enrollment target sits among peer trials

42 501st of 679 higher than 175 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00183365, the US trial registry maintained by the National Library of Medicine. NCT00183365 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.